Opportunity

DIBBS #SPE2DP-26-T-2960

DLA Solicitation for Moxifloxacin Hydrochloride Tablets for U.S. Navy Ships

Posted

April 20, 2026

Respond By

April 27, 2026

Identifier

SPE2DP-26-T-2960

NAICS

424210

This opportunity involves the Defense Logistics Agency Troop Support Medical Supply Chain Pharmacy FSA seeking Moxifloxacin Hydrochloride pharmaceuticals for delivery to two U.S. Navy vessels. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - Contracting office located at 700 Robbins Avenue, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. (NDC00093-7387-56) - DR REDDY'S LABORATORIES, INC. (NDC55111-0112-30) - RISING PHARMA HOLDINGS, INC. (NDC57237-0156-30) - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN 6505-01-503-4772 - Total quantity: 10 bottles (5 for USS Omaha, 5 for USS Barry) - Must be FDA regulated, labeled per Medical Marking Standard No. 1A, and stored at controlled room temperature - Delivery Locations: - USS Omaha (LCS 12), FPO AP 96694 - USS Barry (DDG 52), FPO AP 96692 - Notable Requirements: - Delivery required within 20 days of award, FOB destination - Compliance with Buy American Act and cybersecurity requirements - Packaging and labeling must meet federal medical and FDA standards

Description

MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7016401727) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 4E8M8, Part No: NDC55111-0112-30, Company: DR REDDY'S LABORATORIES, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7016388689) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 4E8M8, Part No: NDC55111-0112-30, Company: DR REDDY'S LABORATORIES, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

View original listing